Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Med Microbiol ; 299(4): 233-46, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19121604

ABSTRACT

The attenuated live bacterial vaccine strain Salmonella enterica Serovar Typhi Ty21a is the main constituent of Vivotif, the only licensed oral vaccine against typhoid fever. The strain was developed in the 1970s by chemical mutagenesis. In the course of this mutagenesis, a number of mutations were introduced into the vaccine strain. Characterisation of the vaccine strain during development as well as release of master- and working seed lots (MSL and WSL) and commercial batches is based on phenotypic assays assessing microbiological and biochemical characteristics of Ty21a. In the current study, we have analysed by DNA sequencing the specific mutations originally correlated with the attenuation of strain Ty21a. These data demonstrate the stability of these mutations for MSLs and WSLs of Ty21a produced between 1980 and 2005. Finally, we have confirmed the correlation of these genetic mutations with the expected phenotypic attenuations for the seed lots used in vaccine manufacture over 25 years.


Subject(s)
Genomic Instability , Salmonella Vaccines/genetics , Salmonella typhi/genetics , DNA, Bacterial/genetics , Humans , Mutation, Missense , Point Mutation , Sequence Analysis, DNA , Vaccines, Attenuated/genetics , Virulence Factors/genetics
2.
Chemotherapy ; 53(3): 177-80, 2007.
Article in English | MEDLINE | ID: mdl-17347563

ABSTRACT

The attenuated Salmonella typhi strain Ty21a is the main constituent of Vivotif, the only attenuated live oral vaccine against typhoid fever. In comparison with antibiotics, the 'magic bullets' which Paul Ehrlich was striving for to treat infectious diseases, this vaccine should be viewed as a 'magic shield', because rather than treating typhoid fever after the infection has started, immunisation with this vaccine strain prevents infection and disease by the induction of specific immune responses. Ty21a is also an attractive carrier for the delivery of heterologous antigens. Recently, we successfully used Ty21a for antigen delivery via the haemolysin secretion system of Escherichia coli, which allows efficient protein secretion from the carrier bacteria.


Subject(s)
Antigens, Heterophile/immunology , Polysaccharides, Bacterial , Typhoid Fever/prevention & control , Typhoid-Paratyphoid Vaccines , Vaccines, Attenuated , Animals , Escherichia coli Proteins/genetics , Escherichia coli Proteins/immunology , Genetic Vectors , Hemolysin Proteins/genetics , Hemolysin Proteins/immunology , Humans , Salmonella typhi/genetics , Salmonella typhi/immunology
3.
FEMS Yeast Res ; 3(2): 223-32, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12702456

ABSTRACT

The ALEU2 gene, encoding beta-isopropylmalate dehydrogenase, was isolated from the non-conventional yeast Arxula adeninivorans. The isolated gene harbours an open reading frame of 1086 bp, encoding a putative protein of 362 amino acids. The derived protein sequence shares a high degree of homology with other fungal beta-isopropylmalate dehydrogenases thus confirming the identity of the gene. The isolated ALEU2 gene was tested for its suitability to complement the auxotrophy of an A. adeninivorans aleu2 host. For this purpose the plasmid pAL-ALEU2m which contains the ALEU2 gene as a selection marker and the 25S rDNA for targeting was employed in transformation experiments. Transformants harboured a single copy of the heterologous DNA and were found to be mitotically stable. For assessment of heterologous gene expression, two model genes were incorporated into the vector: the GFP gene, encoding intracellular green fluorescent protein, and the HSA gene, encoding the secreted human serum albumin. For expression control, both gene sequences were fused to the constitutive A. adeninivorans-derived TEF1 promoter and the Saccharomyces cerevisiae-derived PHO5 terminator. In the respective recombinant strains the GFP was localised in the cytoplasm, whereas more than 95% of the HSA accumulated in the culture medium. In initial fermentation trials using a 200-ml shake flask, maximal HSA product levels were observed after 96 h of cultivation.


Subject(s)
Alcohol Oxidoreductases/genetics , Ascomycota/genetics , DNA, Fungal/genetics , 3-Isopropylmalate Dehydrogenase , Alcohol Oxidoreductases/metabolism , Amino Acid Sequence , Ascomycota/enzymology , Ascomycota/metabolism , Base Sequence , DNA, Fungal/chemistry , Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Genetic Markers , Green Fluorescent Proteins , Luminescent Proteins/genetics , Molecular Sequence Data , Plasmids , Polymerase Chain Reaction , Restriction Mapping , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Serum Albumin/genetics , Transformation, Genetic
4.
FEMS Yeast Res ; 2(3): 349-61, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12702285

ABSTRACT

The early status of strain development for the production of interleukin (IL)-6, IL-8, IL-10, and interferon (IFN) gamma is described. The general approach to generating such strains was to amplify gene sequences encoding the mature forms of the various cytokines by PCR from commercially available cDNA sources. The design of the amplificates allowed an in-frame fusion to an MFalpha1 leader segment contained in two basic expression vectors, pFPMT121-MFalpha1 and pTPSMT-MFalpha1. The two vectors differ in that one harbors the methanol-inducible FMD promoter and the other the constitutive TPS1 promoter as control elements for heterologous gene expression. The most advanced process development example is that of IFNalpha-2a. Here, the MOX promoter derived from another key gene of methanol metabolism is used for expression control. The successful development of a production process for Hansenula polymorpha-derived IFNalpha-2a is summarized. This was achieved by combining genetic engineering of suitable production strains with improved processing capabilities for the secreted cytokine, and by purification procedures from cultures grown in yeast extract-peptone-glycerol-based media.


Subject(s)
Cytokines/biosynthesis , Pichia/genetics , Amino Acid Sequence , Chromatography, High Pressure Liquid , Cytokines/chemistry , Cytokines/genetics , Fermentation , Genetic Vectors , Humans , Molecular Sequence Data , Pichia/enzymology , Pichia/metabolism , Promoter Regions, Genetic , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics
5.
FEMS Yeast Res ; 2(3): 363-9, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12702286

ABSTRACT

The non-conventional dimorphic thermo- and salt-resistant yeast Arxula adeninivorans has been developed as a host for heterologous gene expression. For assessment of the system two model genes have been selected: the GFP gene encoding the intracellular green fluorescent protein, and the HSA gene encoding the secreted human serum albumin. The expression system includes two host strains, namely A. adeninivorans LS3, which forms budding cells at 30 degrees C and mycelia at >42 degrees C, and the strain A. adeninivorans 135, which forms mycelia at temperatures as low as 30 degrees C. For expression control the constitutive A. adeninivorans-derived TEF1-promoter and S. cerevisiae-derived PHO5-terminator were selected. The basic A. adeninivorans transformation/expression vector pAL-HPH1 is further equipped with the Escherichia coli-derived hph gene conferring hygromycin B resistance and the 25S rDNA from A. adeninivorans for rDNA targeting. Transformants were obtained for both budding cells and mycelia. In both cell types similar expression levels were achieved and the GFP was localised in the cytoplasm while more than 95% of the HSA accumulated in the culture medium. In initial fermentation trials on a 200-ml shake flask scale maximal HSA product levels were observed after 96 h of cultivation.


Subject(s)
Hygromycin B/pharmacology , Saccharomycetales/genetics , Blotting, Southern , Fermentation , Genetic Markers , Genetic Vectors , Green Fluorescent Proteins , Luminescent Proteins/biosynthesis , Luminescent Proteins/genetics , Recombinant Proteins/biosynthesis , Saccharomycetales/metabolism , Serum Albumin/biosynthesis , Serum Albumin/genetics , Temperature , Transformation, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...